CA Stock MarketDetailed Quotes

MRV Nuvo Pharmaceuticals Inc

Watchlist
  • 1.350
  • 0.0000.00%
15min DelayTrading Apr 12 09:30 ET
15.37MMarket Cap-19285P/E (TTM)

Nuvo Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-5.20%5.18M
-16.51%5.65M
-126.07%-807K
-13.70%20.84M
-25.68%5.52M
-30.50%5.46M
71.97%6.77M
-39.03%3.1M
922.09%24.15M
-10.46%7.42M
Net income from continuing operations
102.52%447K
99.87%18.28M
111.30%2.03M
-679.97%-32.21M
-333.14%-5.59M
-527.47%-17.77M
565.02%9.15M
-940.43%-17.99M
-221.48%-4.13M
673.92%2.4M
Operating gains losses
-114.97%-779K
-112.83%-16.99M
-114.67%-2.75M
38.34%14.82M
123.23%463K
23.46%5.2M
-2,047.07%-7.98M
128.27%18.77M
134.12%10.71M
-574.52%-1.99M
Depreciation and amortization
-20.93%1.6M
-12.87%1.77M
-8.67%1.9M
-13.03%8.05M
-15.98%1.93M
-10.18%2.02M
-14.29%2.03M
-11.62%2.08M
-3.04%9.26M
-0.91%2.29M
Asset impairment expenditure
-94.99%735K
2,164.41%1.22M
405.56%91K
744.57%18.21M
67.48%3.57M
293,740.00%14.68M
-240.48%-59K
12.50%18K
-91.06%2.16M
864.25%2.13M
Remuneration paid in stock
-21.86%497K
43.13%1.67M
13.79%231K
3,286.49%2.36M
1,245.16%355K
1,277.78%636K
19,300.00%1.16M
3,960.00%203K
30.84%-74K
-6.90%-31K
Remuneration paid in stock
-26.83%30K
-119.05%-8K
-5.71%99K
-12.26%229K
-15.09%45K
-18.00%41K
-20.75%42K
0.00%105K
-42.89%261K
-53.51%53K
Other non cashItems
15.43%1.52M
-74.35%286K
125.62%154K
287.32%4.49M
-3.94%1.02M
-10.29%1.32M
-19.96%1.12M
78.27%-601K
-88.88%1.16M
-75.76%1.07M
Change In working capital
268.91%1.13M
-143.02%-567K
-599.41%-2.56M
1.75%4.89M
147.45%3.73M
-124.18%-669K
-19.39%1.32M
145.43%512K
134.19%4.81M
18.20%1.51M
-Change in receivables
-112.20%-62K
916.10%2.38M
-267.82%-3.08M
-85.58%1.44M
-23.55%2.06M
-78.97%508K
-105.89%-292K
-789.36%-836K
350.41%9.97M
39.84%2.69M
-Change in inventory
200.72%418K
-146.50%-617K
-11.85%-736K
116.15%573K
86.83%-235K
195.86%139K
364.87%1.33M
42.53%-658K
-798.23%-3.55M
-690.73%-1.78M
-Change in payables and accrued expense
132.45%503K
-450.62%-2M
-6.88%1.18M
442.39%2.43M
195.32%2.14M
-2,683.33%-1.55M
122.26%569K
19.25%1.26M
93.97%-710K
255.13%726K
-Change in other current assets
15.81%271K
19.93%-229K
-89.62%77K
150.11%452K
-87.40%-238K
-46.33%234K
-8.75%-286K
178.27%742K
-176.70%-902K
73.76%-127K
-Change in other current liabilities
--0
---109K
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Operating cash flow
-5.20%5.18M
-16.51%5.65M
-126.07%-807K
-13.70%20.84M
-25.68%5.52M
-30.50%5.46M
71.97%6.77M
-39.03%3.1M
922.09%24.15M
-10.46%7.42M
Investing cash flow
Cash flow from continuing investing activities
72.86%-54K
66.15%-44K
-114.17%-36K
57.39%-242K
72.12%-167K
-306.12%-199K
-225.00%-130K
1,254.55%254K
78.40%-568K
-8,457.14%-599K
Net PPE purchase and sale
-2,600.00%-54K
-633.33%-44K
88.18%-13K
41.33%-220K
77.13%-102K
77.78%-2K
85.00%-6K
-400.00%-110K
-351.81%-375K
-6,271.43%-446K
Net intangibles purchas and sale
--0
--0
-106.32%-23K
88.60%-22K
57.52%-65K
-392.50%-197K
---124K
--364K
---193K
---153K
Cash from discontinued investing activities
Investing cash flow
72.86%-54K
66.15%-44K
-114.17%-36K
57.39%-242K
72.12%-167K
-306.12%-199K
-225.00%-130K
1,254.55%254K
78.40%-568K
-8,457.14%-599K
Financing cash flow
Cash flow from continuing financing activities
12.64%-3.28M
-6.81%-3.28M
2.35%-3.53M
39.94%-13.63M
13.61%-3.18M
-0.99%-3.76M
13.50%-3.07M
69.17%-3.62M
-506.17%-22.69M
-9.65%-3.68M
Net issuance payments of debt
12.64%-3.28M
-6.81%-3.28M
2.35%-3.53M
39.94%-13.63M
13.61%-3.18M
-0.99%-3.76M
13.50%-3.07M
69.17%-3.62M
-506.17%-22.69M
-9.65%-3.68M
Cash from discontinued financing activities
Financing cash flow
12.64%-3.28M
-6.81%-3.28M
2.35%-3.53M
39.94%-13.63M
13.61%-3.18M
-0.99%-3.76M
13.50%-3.07M
69.17%-3.62M
-506.17%-22.69M
-9.65%-3.68M
Net cash flow
Beginning cash position
4.83%28.58M
11.76%26.55M
29.68%30.87M
3.42%23.81M
34.59%28.41M
58.91%27.27M
45.72%23.75M
3.42%23.81M
-18.01%23.02M
14.28%21.11M
Current changes in cash
22.34%1.84M
-34.74%2.33M
-1,521.11%-4.38M
679.44%6.98M
-30.96%2.17M
-63.21%1.5M
923.50%3.57M
95.96%-270K
122.32%895K
-36.20%3.14M
Effect of exchange rate changes
333.43%838K
-400.00%-295K
-77.67%48K
185.05%91K
166.22%294K
-162.04%-359K
-111.61%-59K
732.35%215K
89.76%-107K
-17.46%-444K
End cash Position
10.03%31.26M
4.83%28.58M
11.76%26.55M
29.68%30.87M
29.68%30.87M
34.59%28.41M
58.91%27.27M
45.72%23.75M
3.42%23.81M
3.42%23.81M
Free cash from
-2.64%5.12M
-15.54%5.61M
-129.47%-843K
-14.06%20.11M
-21.16%5.35M
-32.62%5.26M
70.40%6.64M
-43.39%2.86M
926.49%23.4M
-18.08%6.79M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -5.20%5.18M-16.51%5.65M-126.07%-807K-13.70%20.84M-25.68%5.52M-30.50%5.46M71.97%6.77M-39.03%3.1M922.09%24.15M-10.46%7.42M
Net income from continuing operations 102.52%447K99.87%18.28M111.30%2.03M-679.97%-32.21M-333.14%-5.59M-527.47%-17.77M565.02%9.15M-940.43%-17.99M-221.48%-4.13M673.92%2.4M
Operating gains losses -114.97%-779K-112.83%-16.99M-114.67%-2.75M38.34%14.82M123.23%463K23.46%5.2M-2,047.07%-7.98M128.27%18.77M134.12%10.71M-574.52%-1.99M
Depreciation and amortization -20.93%1.6M-12.87%1.77M-8.67%1.9M-13.03%8.05M-15.98%1.93M-10.18%2.02M-14.29%2.03M-11.62%2.08M-3.04%9.26M-0.91%2.29M
Asset impairment expenditure -94.99%735K2,164.41%1.22M405.56%91K744.57%18.21M67.48%3.57M293,740.00%14.68M-240.48%-59K12.50%18K-91.06%2.16M864.25%2.13M
Remuneration paid in stock -21.86%497K43.13%1.67M13.79%231K3,286.49%2.36M1,245.16%355K1,277.78%636K19,300.00%1.16M3,960.00%203K30.84%-74K-6.90%-31K
Remuneration paid in stock -26.83%30K-119.05%-8K-5.71%99K-12.26%229K-15.09%45K-18.00%41K-20.75%42K0.00%105K-42.89%261K-53.51%53K
Other non cashItems 15.43%1.52M-74.35%286K125.62%154K287.32%4.49M-3.94%1.02M-10.29%1.32M-19.96%1.12M78.27%-601K-88.88%1.16M-75.76%1.07M
Change In working capital 268.91%1.13M-143.02%-567K-599.41%-2.56M1.75%4.89M147.45%3.73M-124.18%-669K-19.39%1.32M145.43%512K134.19%4.81M18.20%1.51M
-Change in receivables -112.20%-62K916.10%2.38M-267.82%-3.08M-85.58%1.44M-23.55%2.06M-78.97%508K-105.89%-292K-789.36%-836K350.41%9.97M39.84%2.69M
-Change in inventory 200.72%418K-146.50%-617K-11.85%-736K116.15%573K86.83%-235K195.86%139K364.87%1.33M42.53%-658K-798.23%-3.55M-690.73%-1.78M
-Change in payables and accrued expense 132.45%503K-450.62%-2M-6.88%1.18M442.39%2.43M195.32%2.14M-2,683.33%-1.55M122.26%569K19.25%1.26M93.97%-710K255.13%726K
-Change in other current assets 15.81%271K19.93%-229K-89.62%77K150.11%452K-87.40%-238K-46.33%234K-8.75%-286K178.27%742K-176.70%-902K73.76%-127K
-Change in other current liabilities --0---109K--------------0--0------------
Cash from discontinued investing activities
Operating cash flow -5.20%5.18M-16.51%5.65M-126.07%-807K-13.70%20.84M-25.68%5.52M-30.50%5.46M71.97%6.77M-39.03%3.1M922.09%24.15M-10.46%7.42M
Investing cash flow
Cash flow from continuing investing activities 72.86%-54K66.15%-44K-114.17%-36K57.39%-242K72.12%-167K-306.12%-199K-225.00%-130K1,254.55%254K78.40%-568K-8,457.14%-599K
Net PPE purchase and sale -2,600.00%-54K-633.33%-44K88.18%-13K41.33%-220K77.13%-102K77.78%-2K85.00%-6K-400.00%-110K-351.81%-375K-6,271.43%-446K
Net intangibles purchas and sale --0--0-106.32%-23K88.60%-22K57.52%-65K-392.50%-197K---124K--364K---193K---153K
Cash from discontinued investing activities
Investing cash flow 72.86%-54K66.15%-44K-114.17%-36K57.39%-242K72.12%-167K-306.12%-199K-225.00%-130K1,254.55%254K78.40%-568K-8,457.14%-599K
Financing cash flow
Cash flow from continuing financing activities 12.64%-3.28M-6.81%-3.28M2.35%-3.53M39.94%-13.63M13.61%-3.18M-0.99%-3.76M13.50%-3.07M69.17%-3.62M-506.17%-22.69M-9.65%-3.68M
Net issuance payments of debt 12.64%-3.28M-6.81%-3.28M2.35%-3.53M39.94%-13.63M13.61%-3.18M-0.99%-3.76M13.50%-3.07M69.17%-3.62M-506.17%-22.69M-9.65%-3.68M
Cash from discontinued financing activities
Financing cash flow 12.64%-3.28M-6.81%-3.28M2.35%-3.53M39.94%-13.63M13.61%-3.18M-0.99%-3.76M13.50%-3.07M69.17%-3.62M-506.17%-22.69M-9.65%-3.68M
Net cash flow
Beginning cash position 4.83%28.58M11.76%26.55M29.68%30.87M3.42%23.81M34.59%28.41M58.91%27.27M45.72%23.75M3.42%23.81M-18.01%23.02M14.28%21.11M
Current changes in cash 22.34%1.84M-34.74%2.33M-1,521.11%-4.38M679.44%6.98M-30.96%2.17M-63.21%1.5M923.50%3.57M95.96%-270K122.32%895K-36.20%3.14M
Effect of exchange rate changes 333.43%838K-400.00%-295K-77.67%48K185.05%91K166.22%294K-162.04%-359K-111.61%-59K732.35%215K89.76%-107K-17.46%-444K
End cash Position 10.03%31.26M4.83%28.58M11.76%26.55M29.68%30.87M29.68%30.87M34.59%28.41M58.91%27.27M45.72%23.75M3.42%23.81M3.42%23.81M
Free cash from -2.64%5.12M-15.54%5.61M-129.47%-843K-14.06%20.11M-21.16%5.35M-32.62%5.26M70.40%6.64M-43.39%2.86M926.49%23.4M-18.08%6.79M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg